• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型肉毒毒素治疗静止时轻度眉间纹。

OnabotulinumtoxinA treatment of mild glabellar lines in repose.

机构信息

Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.

出版信息

Dermatol Surg. 2010 Dec;36 Suppl 4:2168-71. doi: 10.1111/j.1524-4725.2010.01708.x.

DOI:10.1111/j.1524-4725.2010.01708.x
PMID:21134048
Abstract

BACKGROUND

OnabotulinumtoxinA is an established treatment for glabellar frown lines, but its effects on lines at repose are less well documented.

OBJECTIVE

To assess the effect of onabotulinumtoxinA on elimination of mild lines at repose.

METHODS

Data from two randomized, double-blind, placebo-controlled studies were included. Elimination of mild lines at repose was defined as change from mild to none on the Facial Wrinkle Scale.

RESULTS

Analysis included 183 participants who received 20 U of onabotulinumtoxinA and 64 participants who received placebo, all with mild lines at repose at baseline. Participants were evaluated 7, 30, 60, 90, and 120 days posttreatment. Compared to placebo, onabotulinumtoxinA-treated participants were significantly more likely to have their lines at repose eliminated at each study day; [odds ratios ranged from 42.7 (95% confidence interval (CI)=12.9-141.9) at day 30 to 4.9 (95% CI=2.2-10.8) at day 120 (p<.0001 at each day)]. The highest response rate was observed at day 30 (68%).

CONCLUSION

OnabotulinumtoxinA has demonstrated the ability to eliminate mild glabellar lines at repose for a significant number of patients. This effect, albeit more subtle than the effect on dynamic or more severe glabellar lines, may be an important treatment goal for patients who seek a smoother appearance at repose.

摘要

背景

肉毒毒素 A 是治疗眉间竖纹的成熟疗法,但关于其对休息时皱纹的效果的文献记载较少。

目的

评估肉毒毒素 A 对消除轻度休息时皱纹的效果。

方法

纳入了两项随机、双盲、安慰剂对照研究的数据。消除轻度休息时皱纹的定义为在面部皱纹量表上从轻度变为无。

结果

分析纳入了 183 名接受 20U 肉毒毒素 A 治疗和 64 名接受安慰剂治疗的参与者,所有参与者基线时均有轻度休息时皱纹。参与者在治疗后 7、30、60、90 和 120 天接受评估。与安慰剂相比,接受肉毒毒素 A 治疗的参与者在每个研究日更有可能消除休息时的皱纹;[优势比范围从第 30 天的 42.7(95%置信区间(CI)=12.9-141.9)到第 120 天的 4.9(95%CI=2.2-10.8)(p<.0001,在每个日期间)]。在第 30 天观察到最高的应答率(68%)。

结论

肉毒毒素 A 已证明有能力消除相当多患者的轻度眉间休息时皱纹。这种效果虽然不如对动态或更严重的眉间皱纹的效果明显,但可能是寻求休息时更平滑外观的患者的一个重要治疗目标。

相似文献

1
OnabotulinumtoxinA treatment of mild glabellar lines in repose.A型肉毒毒素治疗静止时轻度眉间纹。
Dermatol Surg. 2010 Dec;36 Suppl 4:2168-71. doi: 10.1111/j.1524-4725.2010.01708.x.
2
Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.无蛋白结合的新型利斯毒素 A 非劣效于另一种肉毒毒素 A 治疗眉间纹。
Dermatol Surg. 2010 Dec;36 Suppl 4:2146-54. doi: 10.1111/j.1524-4725.2010.01706.x.
3
Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.一项比较使用 1:1.5 剂量转换比的 IncobotulinumtoxinA 和 OnabotulinumtoxinA 治疗皱眉纹的 IV 期研究。
J Cosmet Dermatol. 2012 Dec;11(4):267-71. doi: 10.1111/jocd.12001. Epub 2012 Oct 2.
4
Commentary: Revisiting the data: mild resting glabellar lines improve with onabotulinumtoxinA.
Dermatol Surg. 2010 Dec;36 Suppl 4:2172-4. doi: 10.1111/j.1524-4725.2010.01800.x.
5
A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines.20单位的A型肉毒杆菌毒素(onabotulinumtoxinA)与30单位的A型肉毒杆菌毒素(incobotulinumtoxinA)治疗眉间纹的随机双盲对照研究
J Cosmet Laser Ther. 2012 Dec;14(6):296-303. doi: 10.3109/14764172.2012.738913. Epub 2012 Nov 15.
6
The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.注射用A型肉毒毒素治疗中重度眉间纹的疗效与安全性。
Plast Reconstr Surg. 2015 Mar;135(3):732-741. doi: 10.1097/PRS.0000000000001032.
7
A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines.一项随机双盲试验,旨在研究注射用A型肉毒毒素(IncoBotulinumtoxinA)与A型肉毒毒素(OnabotulinumtoxinA)治疗眉间皱纹的等效性。
Dermatol Surg. 2015 Nov;41(11):1310-9. doi: 10.1097/DSS.0000000000000531.
8
Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.一项新的肉毒毒素 A 治疗眉间纹的随机、安慰剂对照研究:疗效和安全性。
Dermatol Surg. 2009 Dec;35(12):1893-901. doi: 10.1111/j.1524-4725.2009.01235.x.
9
Long-term treatment of glabellar rhytides using onabotulinumtoxina.眉间纹的肉毒毒素 A 长期治疗。
Dermatol Surg. 2011 Jul;37(7):918-28. doi: 10.1111/j.1524-4725.2011.02024.x. Epub 2011 May 16.
10
Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.两种肉毒毒素 A 制剂治疗鱼尾纹的比较:一项分割面部、双盲、概念验证研究。
Dermatol Surg. 2010 Dec;36 Suppl 4:2155-60. doi: 10.1111/j.1524-4725.2010.01798.x.

引用本文的文献

1
Botulinum neurotoxins: Future innovations.肉毒神经毒素:未来的创新。
Medicine (Baltimore). 2023 Jul 1;102(S1):e32378. doi: 10.1097/MD.0000000000032378.
2
Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact.肉毒毒素(注射用A型肉毒毒素)治疗眉间纹:发展、见解和影响。
Medicine (Baltimore). 2023 Jul 1;102(S1):e32375. doi: 10.1097/MD.0000000000032375.
3
Avoiding Complications on the Upper Face Treatment With Botulinum Toxin: A Practical Guide.避免肉毒毒素治疗上面部并发症:实用指南。
Aesthetic Plast Surg. 2022 Feb;46(1):385-394. doi: 10.1007/s00266-021-02483-1. Epub 2021 Aug 2.
4
Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles.三个治疗周期内重复使用A型肉毒杆菌毒素治疗静止期眉间纹。
Dermatol Surg. 2016 Sep;42(9):1094-101. doi: 10.1097/DSS.0000000000000704.
5
Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.全球美学共识:A型肉毒毒素——基于证据的综述、新概念以及美学应用的共识性建议,包括并发症的最新情况
Plast Reconstr Surg. 2016 Mar;137(3):518e-529e. doi: 10.1097/01.prs.0000475758.63709.23.
6
[Botulinum toxin in dermatology].[肉毒杆菌毒素在皮肤科的应用]
Hautarzt. 2014 Feb;65(2):133-43; quiz 144-5. doi: 10.1007/s00105-013-2744-5.